RECURRENT NODAL MARGINAL ZONE LYMPHOMA
Clinical trials for RECURRENT NODAL MARGINAL ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NODAL MARGINAL ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT NODAL MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo aims to tackle lymphoma in communities often left behind
Disease control Recruiting nowThis early-stage trial tests two oral drugs, zanubrutinib and sonrotoclax, for people with B-cell non-Hodgkin lymphoma that has returned or not responded to prior treatment. The study focuses on Black, Hispanic, and other underrepresented groups to improve access and outcomes. Ab…
Matched conditions: RECURRENT NODAL MARGINAL ZONE LYMPHOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 10:26 UTC
-
New combo therapy aims to boost lymphoma remission after transplant
Disease control Recruiting nowThis study tests whether adding the drug epcoritamab to standard chemotherapy and a stem cell transplant can improve outcomes for people with large B-cell lymphoma that has returned or not responded to prior treatment. About 25 adults will receive epcoritamab plus chemotherapy be…
Matched conditions: RECURRENT NODAL MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Joseph Tuscano • Aim: Disease control
Last updated May 26, 2026 10:23 UTC